Clinical Trial Update: Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

View source ↗

Summary

Results from a completed clinical trial show persistence of bactericidal antibodies in adolescents and adults after a single dose of Menactra vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease
• Meningitis

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Infections, Meningitis | Status: COMPLETED | Results posted: 2011-01-13